Evaluation of the Relationship Between Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women

Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04407572

Enrollment

Registered

2020-05-29

Start date

2020-04-20

Completion date

2020-06-14

Last updated

2020-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID, Vitamin D Deficiency, Zinc Deficiency

Brief summary

Zinc d vitamin and b12 serum levels in covid-19 positive pregnants will be compared in terms of patients' responses to computed tomography and treatment.

Detailed description

Serum zinc, vitamin d vitamin b12 levels of 45 patients will be measured and evaluated together with the information of the patients.

Interventions

OTHERSerum zinc, vitamin d vitamin b12 levels .

Serum zinc, vitamin d vitamin b12 levels of 45 patients will be measured and evaluated together with the information of the patients.

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

* covid-19 positive pregnant women * under 18 or more than 45 years old

Exclusion criteria

* vitamin D , Vitamin B12 or Zinc supplement use * Multivitamine use * have taken vitamin supplements in the past 3 months * use of medicines for vitamin deficiency * having metabolic disease covid-19 negative pregnant women

Design outcomes

Primary

Measure	Time frame	Description
Serum zinc, vitamin d vitamin b12 deficiency levels	2 months	Serum zinc, vitamin d vitamin b12 levels of 45 patients will be measured and evaluated together with the information of the patients.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026